Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD (ADXN)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
3.21(c) 3.19(c) 3.24(c) 3.5(c) 3.37(c) Last
57 403 92 422 100 963 440 423 174 569 Volume
-0.31% -0.62% +1.57% +8.02% -3.71% Change
More quotes
Company
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health.It develops novel, orally available, and small molecule allosteric modulators for neurological disorders.The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
01/09 ADDEX THERAPEUTICS : Equity Research Report Update Issued by valuationLAB
01/08 ADDEX THERAPEUTICS : Equity Research Report Update Issued by valuationLAB
01/04 INDIVIOR : inks deal to develop new drugs
01/03 ADDEX THERAPEUTICS : and Indivior Sign Strategic Partnership to Accelerate Devel..
2017 ADDEX THERAPEUTICS : Van Leeuwenhoeck Issues Initiation of Coverage Research Rep..
2017 ADDEX THERAPEUTICS : ADX71441 Program Awarded $5.3 Million Grant from US Nationa..
2017 ADDEX THERAPEUTICS : Reports First Half 2017 Operating Highlights and Financial ..
2017 ADDEX THERAPEUTICS : Makes Changes to Executive Management Team
2017 ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at 2017 Annual Ge..
2017 ADDEX THERAPEUTICS : Annual General Meeting Scheduled for 22 June 2017
More news
Sector news : Biotechnology & Medical Research - NEC
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
10:26aRed Flag Watch for Noble, Roger Mills, Dewey, Custer, Blaine, Kingfisher and .. 
01/08Addex Therapeutics : Equity Research Report Update Issued by valuationLAB  
2017Red Flag Warning for Alfalfa, Kay, Major, Garfield, Noble, Roger Mills and De..
1
2017Red Flag Watch for Alfalfa, Kay, Major, Garfield, Noble, Roger Mills and Dewe.. 
2017Travelers Advisory thru Wed. Morning N. TX panhandle. Some moderate snowfall .. 
More tweets
Qtime:59
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Timothy Dyer Chief Executive Officer & Director
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD41.48%56
CELLTRION, INC.--.--%40 725
IQVIA HOLDINGS INC2.07%20 784
LONZA GROUP2.47%20 682
INCYTE CORPORATION-3.23%19 342
ALNYLAM PHARMACEUTICALS, INC.-1.90%12 256